COVID-19 in Patients with Hematologic Malignancies: A Single-Center Experience

Introduction:The emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and subsequent coronavirus-19 (COVID-19) pandemic has impacted hematologic malignancies (HM) care worldwide. Reported risk factors for severe COVID-19 presentation include older age, medical comorbidities,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilde, Lindsay, Binder, Adam F., Carabasi, Matthew, Filicko-O'Hara, Joanne, Wagner, John L., Alpdogan, Onder, Kasner, Margaret, Klumpp, Thomas R., Martinez-Outschoorn, Ubaldo, Palmisiano, Neil, Keiffer, Gina, Grosso, Dolores, Millenson, Michael, MacKenzie, Amy R., Zibelli, Allison, Flomenberg, Neal, Porcu, Pierluigi, Gergis, Usama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
901.Health Services Research-Non-Malignant Conditions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330274/
http://dx.doi.org/10.1182/blood-2020-140719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330274/
http://dx.doi.org/10.1182/blood-2020-140719

Ejemplares similares